Latest News

Learn how Vineti is enabling the success of personalized therapies

June 21, 2017

Vineti scores $13M+, launches cloud-based platform for cell therapies

Publication: FierceBiotech

June 21, 2017

Vineti receives $13.8M investment in drug development software platform

Publication: Contract Pharma

June 21, 2017

Mayo backs software startup looking to accelerate cancer cure process

Publication: Twin Cities Business

June 21, 2017

Mayo Clinic Ventures funds new cancer-fighting cell, gene therapy

Publication: Post Bulletin

June 21, 2017

Mayo Clinic, GE-backed startup secures $13.7M in Series A funding

Publication: Becker's Health IT & CIO Review

June 20, 2017

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

Publication: TechCrunch

June 20, 2017

GE Ventures, Mayo Clinic Ventures and DFJ invest $13.75M in first software platform to accelerate cancer cure process and delivery

Publication: GlobeNewswire

June 20, 2017

Vineti takes aim at cancer cell-therapy market with $13.8 million Series A

Publication: The Wall Street Journal

June 20, 2017

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing

Publication: MedCity News

January 12, 2017

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference

Publication: Cell & Gene Therapy World

1
2
3
4
5
6
7 (current)
8